Publications by authors named "Ramon Alemany"

Claim this Profile
T
Toxicity and Biodistribution of the Oncolytic Virus VCN-01 Following Intracranial Injection in Syrian Hamsters.
Daniel Palacios-Alonso, Miriam Bazan-Peregrino, Marta Zalacain, Lucía Marrodán, Ana Mato-Berciano, Ramon Alemany

Hum Gene Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis.
Marc Otero-Mateo, Francesc Estrany, Sabrina Arcas-Márquez, Laura Moya-Borrego, Giancarlo Castellano, Ramon Alemany

Mol Ther Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the power of NAP-CNB's machine learning-enhanced tumor neoantigen prediction.
Almudena Mendez-Perez, Andres M Acosta-Moreno, Carlos Wert-Carvajal, Pilar Ballesteros-Cuartero, Ruben Sánchez-García, Ramon Alemany

Elife· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial.
Xavier Garcia-Del-Muro, Begoña P Valderrama, Ana Medina-Colmenero, Olatz Etxaniz, Regina Gironés Sarrió, Ramon Alemany

Clin Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical protocol phase II study of tumor infiltrating lymphocytes in advanced tumors with alterations in the SWI/SNF complex: the TILTS study.
Juan Martin-Liberal, Elena Garralda, Jesús García-Donas, Juan José Soto-Castillo, Alberto Mussetti, Ramon Alemany

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of the RGD motif from the penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapy.
Alvaro Morales-Molina, Miguel Angel Rodriguez-Milla, Patricia Garcia-Rodriguez, Laura Hidalgo, Ramon Alemany

Mol Ther Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driver mutations in and genes as potential targets for precision immunotherapy in uveal melanoma patients.
Sandra García-Mulero, Roberto Fornelino, Marco Punta, Stefano Lise, Mar Varela, Ramón Alemany

Oncoimmunology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model.
Mariangela Garofalo, Magdalena Wieczorek, Ines Anders, Monika Staniszewska, Michal Lazniewski, Ramon Alemany

Front Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy.
Juan José Soto-Castillo, Lucía Llavata-Marti, Roser Fort-Culillas, Pablo Andreu-Cobo, Rafael Moreno, Ramon Alemany

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models.
Jessica Wenthe, Emma Eriksson, Ann-Charlotte Hellström, Rafael Moreno, Gustav Ullenhag, Ramon Alemany

J Transl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic cellular viroimmunotherapy for canine high-grade gliomas.
Ana Cloquell, Isidro Mateo, Stefano Gambera, Martí Pumarola, Ramon Alemany

J Immunother Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition.
Jessica Wenthe, Sedigheh Naseri, Ann-Charlotte Hellström, Rafael Moreno, Gustav Ullenhag, Ramon Alemany

Mol Ther Oncolytics· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.
Rocio Garcia-Carbonero, Miriam Bazan-Peregrino, Marta Gil-Martín, Rafael Álvarez, Teresa Macarulla, Ramon Alemany

J Immunother Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects.
Miriam Bazan-Peregrino, Rocio Garcia-Carbonero, Berta Laquente, Rafael Álvarez, Ana Mato-Berciano, Ramon Alemany

J Immunother Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation.
Martí Farrera-Sal, Rafael Moreno, Ana Mato-Berciano, María Victoria Maliandi, Miriam Bazan-Peregrino, Ramon Alemany

Mol Ther Oncolytics· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus.
Martí Farrera-Sal, Laura Moya-Borrego, Miriam Bazan-Peregrino, Ramon Alemany

Clin Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transgene codon usage drives viral fitness and therapeutic efficacy in oncolytic adenoviruses.
Estela Núñez-Manchón, Martí Farrera-Sal, Marc Otero-Mateo, Giancarlo Castellano, Rafael Moreno, Ramon Alemany

NAR Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting MHC I restricted T cell epitopes in mice with NAP-CNB, a novel online tool.
Carlos Wert-Carvajal, Rubén Sánchez-García, José R Macías, Rebeca Sanz-Pamplona, Almudena Méndez Pérez, Ramon Alemany

Sci Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11.
Ana Mato-Berciano, Sara Morgado, María V Maliandi, Martí Farrera-Sal, Marta Gimenez-Alejandre, Ramon Alemany

J Control Release· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma.
Juri Kiyokawa, Yoichiro Kawamura, Shanawaz M Ghouse, Simge Acar, Erinç Barçın, Ramon Alemany

Clin Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Codon Usage and Adenovirus Fitness: Implications for Vaccine Development.
Judit Giménez-Roig, Estela Núñez-Manchón, Ramon Alemany, Eneko Villanueva, Cristina Fillat

Front Microbiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness.
Martí Farrera-Sal, Jana de Sostoa, Estela Nuñez-Manchón, Rafael Moreno, Cristina Fillat, Ramon Alemany

Int J Mol Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gold Nanoparticle-Assisted Virus Formation by Means of the Delivery of an Oncolytic Adenovirus Genome.
Luis Sendra, Antonio Miguel, M Carmen Navarro-Plaza, María José Herrero, José de la Higuera, Ramón Alemany

Nanomaterials (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors.
David Ruano, José A López-Martín, Lucas Moreno, Álvaro Lassaletta, Francisco Bautista, Ramón Alemany

Mol Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses.
Martí Farrera-Sal, Cristina Fillat, Ramon Alemany

Cancers (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis